Inactive Instrument

Insiders Novo Nordisk A/S Xetra

Equities

End-of-day quote Xetra Other stock markets
- ^EUR	-

06/06	Novo Nordisk braces for Ozempic rivals in China	RE
06/06	European equities gain on tech boost in run-up to ECB	RE

Adocia appoints Director of Operations	04/06	CF
Novo Nordisk CEO: Demand for Wegovy outstrips supply	02/05	MT
Germany's Evotec appoints Christian Wojczewski as CEO	24/04	RE
Kasim Kutay, CEO of Novo Holdings: Catalent purchase marks new era of acquisitions	12/03	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	07/03
WeightWatchers shares drop as Oprah Winfrey decides to exit board	29/02	RE
Novo Nordisk CEO Jorgensen: Demand will outstrip supply for years to come	08/02	MT
Jorgensen, CEO of Novo Nordisk: €10bn investment to meet demand for its weight loss drugs	31/01	MT
Evotec says it promptly reported share trades withheld by former CEO	22/01	RE
Kasim Kutay, CEO of Novo Holdings: Acquisition Offensive	19/01	MT
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!	28/11	MT
Lars Fruergaard Jorgensen, CEO of Novo Nordisk: dose limitation to continue until 2024	02/11	MT
Novo Says Wegovy Is Growth Driver in US	02/11	MT
Recordati, Zdravkovic vice president R&D and Sabia new CMO	16/23/16	AN
Novo Nordisk Halts Ozempic Study	11/23/11	MT
INTERVIEW - PepsiCo CFO Hugh Johnston: Ozempic has no impact on sales	11/23/11	MT
BP Chair Helge Lund Won't Become New Chief Executive	15/23/15	MT
BP Chairman Withdraws from Consideration as Next CEO	15/23/15	MT
Novo-appointed director steps down from ConvaTec board	08/23/08	AN
Novo CEO on Ozempic, Wegovy Demand, Acquisition Strategy	01/23/01	MT